Below, Jennifer E.

Bharaj, Bhupinder

Boright, Andrew P.

Bull, Shelley B.

Canty, Angelo J.

Cleary, Patricia A.

Cox, Nancy J.

Hosseini, S. Mohsen

Lachin, John M.

Nicolae, Dan

Paterson, Andrew D.

Shen, Enqing

Sun, Lei

Sylvestre, Marie-Pierre

Waggott, Daryl

Wong, Isidro

English

PubMed

Chen

Crossref

A Genome-Wide Association Study Identifies a Novel Major Locus for Glycemic Control in Type 1 Diabetes, as Measured by Both A1C and Glucose

1.0: Rapid haplotype reconstruction and missing genotype inference. Presented at the annual meeting of the

A 100K genome-wide association scan for diabetes and related traits in the Framingham Heart Study: replication and integration with other genome-wide datasets.

A genetic variant in HK1 is associated with proanemic state and A1C but not other glycemic control-related traits. Diabetes

A genome-wide association study identiﬁes novel risk loci for type 2 diabetes.

A genomewide scan for loci linked to plasma levels of glucose and HbA(1c) in a community-based sample of Caucasian pedigrees: The Framingham Offspring Study. Diabetes

A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels.

A second generation human haplotype map of over 3.1 million SNPs.

A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk.

Analysis of Longitudinal Data.

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop,

Clustering of long-term complications in families with diabetes

Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations.

Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion.

DCCT/EDIC Research Group. The effect of intensive glycemic treatment on coronary artery calciﬁcation

de Geus EJ. The heritability of HbA1c and fasting blood glucose in different measurement settings. Twin Res Hum Genet

Design and methodologic considerations for the feasibility phase.

Diabetes Control and Complications Trial Research Group. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the Diabetes Control and Complications Trial: a randomized, controlled trial.

Diabetes Control and Complications Trial Research Group. Manual of Operations for the Diabetes Control and Complications Trial.

Diabetes Control and Complications Trial, Epidemiology of Diabetes Interventions and Complications Research Group. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.

Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial.

Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications.

Effect of intensive diabetes treatment on nerve conduction

Effect of intensive therapy on the development and progression of diabetic nephropathy

Estimation of signiﬁcance thresholds for genomewide association scans.

factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study.

FinnDiane Study Group. Heritability of proliferative diabetic retinopathy.

Genetics of Kidneys in Diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes.

Genome-wide association analysis of metabolic traits in a birth cohort from a founder population.

Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes.

Genome-wide association with diabetes-related traits in the Framingham Heart Study.

Genome-wide linkage scans for fasting glucose, insulin, and insulin resistance in the National Heart, Lung, and Blood Institute Family Blood Pressure Program: evidence of linkages to chromosome 7q36 and 19q13 from meta-analysis.

HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins.

Hemoglobin A1c measurements over nearly two decades: sustaining comparable values throughout

High-resolution quantitative trait locus analysis reveals multiple diabetes susceptibility loci mapped to intervals 800 kb

Implementation of treatment protocols in the Diabetes Control and Complications Trial. Diabetes Care

Meigs JB, on behalf of MAGIC. Common variants at ten loci inﬂuence glycated hemoglobin levels via glycemic and non-glycemic pathways.

Metabolic control as reﬂected by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus: combined longitudinal analysis including 27,035 patients from 207 centers in Germany and Austria during the last decade.

NCI-NHGRI Working Group on Replication in Association Studies, Chanock

Novel association of HK1 with glycated hemoglobin in a non-diabetic population: a genome-wide evaluation of 14,618 participants in the Women’s Genome Health Study.

Parving HH. Is diabetic nephropathy an inherited complication? Kidney Int

PLINK: a tool set for whole-genome association and population-based linkage analyses.

Population structure and eigenanalysis. PLoS Genet

Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus.

QTL analyses: power, precision, and accuracy. In Molecular Dissection of Complex Traits.

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.

Risk factors for cardiovascular disease in IDDM: a study of identical twins.

SORCS1: a novel human type 2 diabetes susceptibility gene suggested by the mouse.

The effect of intensive diabetes therapy on measures of autonomic nervous system function

The effect of intensive diabetes therapy on the development and progression of neuropathy.

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Variants in MTNR1B inﬂuence fasting glucose levels.

Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels.

Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2809960

A Genome-Wide Association Study Identifies a Novel Major Locus for Glycemic Control in Type 1 Diabetes, as Measured by Both A1C and Glucose

Abstract

Similar works

Full text

Available Versions

Crossref